Rosenberg Noah L.
Insider CIK 1579649 · ESPR Chief Medical Officer · RTRX Chief Medical Officer · VRCA CMO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VRCA Verrica Pharmaceuticals In | P Buy | 2026-08-18 | 2026-08-18 | 2,030 | $4.92 | $10.0K | 8,587 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2026-08-18 | 2026-08-18 | 2,030 | $4.92 | $10.0K | 8,587 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2026-08-17 | 2026-08-18 | 4,200 | $4.91 | $20.6K | 6,557 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2026-08-17 | 2026-08-18 | 4,200 | $4.91 | $20.6K | 6,557 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | A Award deriv | 2026-06-05 | 2026-06-09 | 233,840 | — | $0 | 233,840 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy deriv | 2025-11-25 | 2025-11-25 | 589 | — | $0 | 589 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | P Buy | 2025-11-25 | 2025-11-25 | 2,357 | $4.24 | $10.0K | 2,357 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | A Award deriv | 2025-03-24 | 2025-03-26 | 325,000 | — | $0 | 325,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-08-17 | 2021-08-17 | 1,407 | $17.12 | $24.1K | 47,614 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-08-13 | 2021-08-17 | 4,500 | — | $0 | 49,021 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-07-28 | 2021-07-29 | 1,250 | $13.81 | $17.3K | 44,521 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-05-12 | 2021-05-13 | 375 | $19.46 | $7.3K | 45,594 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-05-11 | 2021-05-13 | 375 | $19.14 | $7.2K | 45,969 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-08 | 2021-02-09 | 1,125 | $31.58 | $35.5K | 46,344 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-05 | 2021-02-09 | 1,125 | $31.41 | $35.3K | 47,469 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-03 | 2021-02-03 | 1,250 | $28.91 | $36.1K | 44,657 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-03 | 2021-02-03 | 563 | $28.91 | $16.3K | 44,094 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-02-03 | 2021-02-05 | 4,500 | — | $0 | 48,594 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-02 | 2021-02-02 | 1,250 | $30.75 | $38.4K | 46,470 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-02 | 2021-02-02 | 563 | $30.75 | $17.3K | 45,907 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-01-31 | 2021-02-02 | 5,000 | — | $0 | 47,720 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2021-01-21 | 2021-01-25 | 57,500 | — | $0 | 57,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-01-21 | 2021-01-25 | 15,000 | — | $0 | 42,720 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-09-23 | 2020-09-23 | 750 | $18.48 | $13.9K | 27,555 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-09-22 | 2020-09-22 | 750 | $18.59 | $13.9K | 28,305 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2020-09-18 | 2020-09-22 | 3,000 | — | $0 | 29,055 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-07-28 | 2020-07-30 | 870 | $20.49 | $17.8K | 26,055 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-05-12 | 2020-05-13 | 527 | $16.98 | $8.9K | 26,728 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-03-05 | 2020-03-09 | 1,790 | $15.36 | $27.5K | 27,255 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2020-03-05 | 2020-03-09 | 5,000 | — | $0 | 29,045 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2020-01-31 | 2020-01-31 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2020-01-31 | 2020-01-31 | 9,000 | — | $0 | 9,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2020-01-31 | 2020-01-31 | 55,000 | — | $0 | 55,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2020-01-31 | 2020-01-31 | 9,000 | — | $0 | 22,500 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2019-07-31 | 2019-07-31 | 1,250 | $20.07 | $25.1K | 13,500 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2019-07-30 | 2019-07-31 | 1,250 | $19.82 | $24.8K | 14,750 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2019-05-09 | 2019-05-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2019-05-09 | 2019-05-10 | 6,000 | — | $0 | 6,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2019-05-09 | 2019-05-10 | 6,000 | — | $0 | 16,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2018-07-26 | 2018-07-30 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2018-07-26 | 2018-07-30 | 65,000 | — | $0 | 65,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2018-07-26 | 2018-07-30 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2013-07-23 | 2013-07-25 | 13,500 | — | $0 | 13,500 | SEC↗ |